Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Calithera Biosciences Q2 Sales $3.00M, Same YoY

Calithera Biosciences Q2 Sales $3.00M, Same YoY

Calithera Biosciences (NASDAQ:CALA) reported $3.00 million in sales this quarter. This is the same as the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Calithera Biosciences (NASDAQ:CALA) reported $3.00 million in sales this quarter. This is the same as the same period last year.

Earnings

Recap: HP Q2 Earnings

By Benzinga Insights

May 30, 4:20 PM

HP (NYSE:HPQ) reported its Q2 earnings results on Tuesday, May 30, 2023 at 04:15 PM. Here’s what investors…

HPQ

Mamamancini’s Secures Over 4000 New Spots On Shelves Of Tier-1 Retailers

By Shivani Kumaresan

July 29, 2:14 PM

MamaMancini’s Holdings Inc (NASDAQ:MMMB) has secured new customer authorizations, representing over 4000 new spots on the shelves of tier-1 nationwide…

MMMB

Jeff Bezos Pulls An Elon Musk And Heaps Praise On Dogecoin Creator

By Shivdeep Dhaliwal

December 24, 11:17 PM

It is routine to find Tesla Inc (NASDAQ: TSLA) CEO Elon Musk in the comments section of Dogecoin (CRYPTO: DOGE) co-creator Billy Markus' tweet but there's

$DOGE

TTM Technologies Q4 Adj. EPS $0.41 Beats $0.38 Estimate, Sales $617.16M Miss $658.57M Estimate

By Michael Horton

February 8, 5:06 PM

TTM Technologies (NASDAQ:TTMI) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.38 by 7.89 percent. This is a 20.59 percent increase over earnings of $0.34 per share from the

TTMI

Calithera Biosciences Q2 Sales $3.00M, Same YoY

Related Posts

Recap: HP Q2 Earnings

Mamamancini’s Secures Over 4000 New Spots On Shelves Of Tier-1 Retailers

Jeff Bezos Pulls An Elon Musk And Heaps Praise On Dogecoin Creator

TTM Technologies Q4 Adj. EPS $0.41 Beats $0.38 Estimate, Sales $617.16M Miss $658.57M Estimate